Four-year follow-up of TYPHOON (trial to assess the use of the CYPHer sirolimus-eluting coronary stent in acute myocardial infarction treated with BallOON angioplasty).

@article{Spaulding2011FouryearFO,
  title={Four-year follow-up of TYPHOON (trial to assess the use of the CYPHer sirolimus-eluting coronary stent in acute myocardial infarction treated with BallOON angioplasty).},
  author={Christian M Spaulding and Emmanuel Teiger and Philippe Commeau and Olivier Varenne and Ezio Bramucci and Michel S. Slama and Keavin Beatt and Ashok M Tirouvanziam and Lech Polonski and Pieter R. Stella and Richard Clugston and Jean Fajadet and Xavier de Boisgelin and Christophe Bode and Didier Carri{\'e} and Andrejs Ērglis and B{\'e}la Merkely and Stefan Hosten and Ana C. Cebri{\'a}n and Patrick Wang and H. J. Stoll and P. G. Henry},
  journal={JACC. Cardiovascular interventions},
  year={2011},
  volume={4 1},
  pages={14-23}
}
OBJECTIVES The aim of this study was to assess the long-term safety and efficacy of the CYPHER (Cordis, Johnson and Johnson, Bridgewater, New Jersey) sirolimus-eluting coronary stent (SES) in percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI). BACKGROUND Concern over the safety of drug-eluting stents implanted during PCI for STEMI remains, and long-term follow-up from randomized trials are necessary. TYPHOON (Trial to assess the use of the cYPHer… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 49 extracted citations

Similar Papers

Loading similar papers…